Researcher at the Institute of Medical Biology. In 2016, she was awarded the Scientific Qualification Level IIa by the Slovak Academy of Sciences. She is the author / co-author of 23 original scientific papers (WOS / SCOPUS) (12 first-author works), cited 217 times. Has experience with several molecular biology analyzes, gene analyzes (DNA, RNA, PCR, qPCR, seqRNA analysis), gene region design, primers and sequencing analyzes, phylogenetic studies of different species of organisms (MEGA), gene variability, LC / MS methods, immunoprecipitations, protein analyzes, imaging of cell interactions by fluorescence microscopy, ChiP analyzes, many years of experience in culturing various tumor cells, culturing various bacterial species and genome, species identification, definition of cell proliferation and metabolic activity. Extensive experience in GMO preparation, transformation, transduction, transfection of genomes using retroviruses, letiviruses and bacterial cells. She completed a work placement at The Medical University of South Carolina Carolina, MUSC, Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Hollings Cancer Center), in prof. Rosenzweig S.A., in Charleston, USA, where she gained experience in the field modern molecular and biological analyzes (the output is the article Šemeláková et al., Translational Oncology 2019). She carried out a working stay at a specialized workplace at the Rowett Research Institute, Aberdeen, Scotland (high citation articles: Regensbogenová M. (Šemeláková) et al., FEMS Microbiology Letters 2004; Letters in Applied Microbiology 2004; Acta Protozoologica 2004). Marie Curie fellowship, international ERCULE project (CORDIS QLRI-CT- 2000-01455, coordinated by UK, Rowett Research Institute, Aberdeen, Scotland, microbiological laboratory, and prof. Newbold J.C. Graduate of 2022 from the Fulbright Research and Research Lecture at Wistar Institute, Gene Expression and Regulation Program, Cancer Center, Philadelphia, USA. The Wistar Institute is one of the oldest research centers in the United States, where the first vaccines were developed: the measles, mumps and rubella (MMR) vaccine, the Zika virus vaccine, two Powassan virus vaccines, a rotavirus vaccine and others. She has been involved in solving a research role within the international lead biomedical research in cancer, immunology, infectious and vaccine development, where a new potential path is being sought for the development of a Epstein-Barr virus (EBV) therapist. In the past she was a co-investigator of 11 projects (VEGA, APVV) and leader of 1 VVGS project UPJŠ. It contributed to the GenBank database 747 DNA sequences, 158 protein sequences, thus provided data for the scientific community. Its scientific attention has been paid in recent years to the effect of bioactive compounds on metastasis, the antiangiogenic effect studied on the original and resistant adenocarcinoma colon, with a characterized membrane tumor cell profile and erythropoietin receptor role. Thanks to her rich work experience abroad, he provides students with an overview of the most modern methods used in the diagnosis of various diseases in the world. She is a trainer of graduates and doctoral students. Awarded European Cancer Research Association, EACR: https://www.eacr.org/news/image-of-the-month-july2017, NEDD9 protein study during SCC9 metastatic process shows high actin activation fibers on the surface of head and neck cancer cells.

Pavol Jozef Safarik University in Kosice, 1998, Biology

Pavol Jozef Safarik University in Kosice, 2000, Molecular biology

Pavol Jozef Safarik University in Kosice, 2004, Genetics